Researchers at the Technion-Israel Institute of Technology have developed a breathalyzer, named Na-Nose, that can diagnose up to seventeen potential disease with a high degree of accuracy. The team was led by Hossam Haick, who an interview with CNN said, “"I would say our technology in many cases (is) equivalent to the accuracy of the currently available invasive technology." The device, which unlike traditional invasive techniques which require blood samples or other procedures, can analyze a user’s breath for Parkinson’s disease, various cancers, kidney failure and multiple sclerosis and Chrohn’s disease with 86% accuracy. The team foresees the potential for their technology to be adapted for smartphone use, and could become available beyond clinical applications. Source: Susan Scutti, CNN; Nakhley and colleagues, European Respiratory Journal.
Na-Nose is an Experimental Breathalyzer that Smells Out Diseases
The contents of this website were developed under a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR grant number 90RE5025-01-00). NIDILRR is a Center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this website do not necessarily represent the policy of NIDILRR, ACL, HHS, and you should not assume endorsement by the Federal Government.